Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,051Revenue (TTM) $M1,045Net Margin (%)-46.2Altman Z-Score7.3
Enterprise Value $M14,691EPS (TTM) $-3.0Operating Margin %-58.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-61.8Higher ROA y-yN
Price/Book5.710-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales13.75-y EBITDA Growth Rate %--Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-13.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-20.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M172ROIC % (ttm)-19.6Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BMRN is held by these investors:



BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIENAIME JEAN JACQUESCEO 2017-01-26Sell10,000$84.222.18view
BIENAIME JEAN JACQUESCEO 2017-01-11Sell8,000$90.58-4.99view
BIENAIME JEAN JACQUESCEO 2017-01-09Sell8,000$88.49-2.75view
SPIEGELMAN DANIEL KEVP, CFO 2017-01-09Sell5,000$90-4.38view
BIENAIME JEAN JACQUESCEO 2016-12-30Sell8,000$83.62.94view
FUCHS HENRY JPresident, Worldwide R&D 2016-11-25Sell15,000$87.4-1.53view
BIENAIME JEAN JACQUESCEO 2016-11-22Sell139,487$86.62-0.65view
Davis George EricEVP, General Counsel 2016-11-18Sell5,000$90.42-4.82view
BIENAIME JEAN JACQUESCEO 2016-11-16Sell41,670$90.97-5.4view
SPIEGELMAN DANIEL KEVP, CFO 2016-11-09Sell20,000$90.61-5.02view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Piotroski F-Score in the Real World Dec 19 2016 
U.S. Elections: What They Might Mean for Investors - JOHCM Commentary Nov 29 2016 
Low Valuation Ratios Lead to Strong Portfolio Returns Sep 13 2016 
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Roche Holdings Definitely Not a Lumbering Giant Jul 11 2016 
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 

More From Other Websites
BioMarin (BMRN) Q4 Loss Narrower than Expected; Sales Beat Feb 24 2017
Edited Transcript of BMRN earnings conference call or presentation 23-Feb-17 9:30pm GMT Feb 24 2017
BioMarin reports 4Q loss Feb 23 2017
BioMarin reports 4Q loss Feb 23 2017
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 23 2017
4:08 pm BioMarin Pharm misses by $0.08, beats on revs; guides FY17 revs below consensus Feb 23 2017
BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results Feb 23 2017
Q4 2016 Biomarin Pharmaceutical Inc Earnings Release - Time Not Supplied Feb 23 2017
Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More Feb 22 2017
JANA Partners Made Massive New Pharma Investments in Q4 Feb 21 2017
Blog Coverage Celgene's Multiple Sclerosis Drug Reported Positive Phase-III Results Feb 21 2017
BioMarin (BMRN) Q4 Earnings: Will it Post a Beat Again? Feb 17 2017
BioMarin Announces 11 Presentations at 13th Annual WORLDSymposium™ 2017 Feb 15 2017
Gilead Sciences & Bristol Myers: Two Wrongs Make a Right? Feb 08 2017
BioMarin to Attend Three Investor Conferences in 1Q17 Feb 08 2017
Your Guide To 2017's Emerging Pharmaceuticals Catalysts Feb 07 2017
BioMarin sues to stop generic version of its $90K-a-year drug Feb 07 2017
BioMarin to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast on... Feb 07 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)